Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0001650648-18-000001
Filing Date
2018-09-11
Accepted
2018-09-11 16:39:53
Documents
1
Effectiveness Date
2018-09-11
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 13195
  Complete submission text file 0001650648-18-000001.txt   14262
Mailing Address 5980 HORTON STREET SUITE 460 EMERYVILLE CA 94608
Business Address 5980 HORTON STREET SUITE 460 EMERYVILLE CA 94608 5105052680
4D Molecular Therapeutics Inc (Filer) CIK: 0001650648 (see all company filings)

EIN.: 473506994 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D | Act: 33 | File No.: 021-321085 | Film No.: 181065206